MELANIE DURHAM: Open Payments
NPI 1730379611 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$523 in 17 payments from 6 companies in 2025. Trend: 2023 $714 · 2024 $552 · 2025 $523
Food & beverage: $523
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 10 | $182 |
| Medtronic, Inc. | 2 | $162 |
| Boston Scientific Corporation | 2 | $110 |
| E.R. Squibb & Sons, L.L.C. | 1 | $29 |
| PFIZER INC. | 1 | $23 |
| Vital Connect, Inc | 1 | $17 |
Products named: LEQVIO, SYMPLICITY G3, FARAPULSE, CAMZYOS, VYNDAQEL, VITALPATCH RTM.
Industry payments across TX — which companies pay providers there.
